chronic obstructive pulmonary disease copy
TRANSCRIPT
![Page 1: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/1.jpg)
Airway DiseasesMay 2013
Mekelle
![Page 2: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/2.jpg)
Chronic Obstructive Pulmonary Disease
![Page 3: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/3.jpg)
COPD
Definition
COPD- a disease state characterized by airflow limitation that is not fully reversible
The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases
![Page 4: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/4.jpg)
COPD includes Chronic bronchitis
Emphysema
Small airway disease
COPD is the fourth leading cause of death in the USA
![Page 5: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/5.jpg)
Risk factors
In the west
Most important is cigarette smoking
In developing countries
Role of household fuels and indoor pollution have important contribution.
![Page 6: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/6.jpg)
Occupational exposure
Air Pollution
Genetic- α-1 Antitrypsin Deficiency
![Page 7: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/7.jpg)
Regarding smoking
The degree of damage to the lung (FEV loss) is proportional to the amount of cigarettes smoked.
Not all smokers develop COPD ( 15%) only; outlining individual susceptibility
Second hand (passive) smokers are also at risk
![Page 8: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/8.jpg)
Regarding asthma and COPD
Dutch hypothesis – asthma and COPD are two diseases in the same spectrum
British hypothesis – different entities
![Page 9: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/9.jpg)
![Page 10: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/10.jpg)
Natural history
Risk of mortality from COPD is closely associated with reduced levels of FEV1
FEV1 is a marker of obstruction
![Page 11: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/11.jpg)
Obstruction leads to hyperinflation.
Hyperinflation leads to impaired diaphragmatic function.
![Page 12: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/12.jpg)
Pathology Cigarette smoke exposure may affect
the large airways, small airways ( 2 mm diameter), and alveolar space
Large airway changes cause cough and
sputum (i.e. the symptoms),
small airways and alveolar changes are responsible for physiologic alterations
![Page 13: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/13.jpg)
Patterns
Emphysema
Defined in anatomic terms
Destruction of the airways
Pan or centri acinar pattern
Chronic bronchitis
Defined in clinical terms
Based on symptoms
![Page 14: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/14.jpg)
Diagnosis Consider COPD in any patient with combination of
these symptoms
Dyspnea
Chronic cough
Chronic sputum production
History of exposure to risk factors
![Page 15: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/15.jpg)
Physical examination is rarely diagnostic in COPD Wheezes here and there
![Page 16: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/16.jpg)
With severe airflow obstruction- use of accessory muscles of respiration- tripod
position
Cyanosis
Systemic wasting Later on
Signs of right sided heart failure
Sometimes Features of systemic inflammation ( ischemic
heart disease osteoporosis ….), poor sleep
![Page 17: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/17.jpg)
Laboratory findings
CXR can be normal or some times shows some hyperinflation. Don’t rule out COPD b/c you have a normal CXR
Pulm Function tests
Low FEV1/FVC
Low peak flow
Some reversibility might be there in the obstruction
![Page 18: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/18.jpg)
Hct – for erythrocytosis
ECG and Echo – for Cor pulmounale
![Page 19: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/19.jpg)
Stage of COPD
We use spirometric parameters
GOLD staging
![Page 20: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/20.jpg)
Management plan has four components
Assess and monitor disease
Reduce risk factors
Manage stable COPD
Manage exacerbations
![Page 21: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/21.jpg)
Assess and monitor
Stage of the disease
Use spirometry and clinical features
![Page 22: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/22.jpg)
Risk factor reduction
Smoking cessation
![Page 23: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/23.jpg)
Stable COPD
Bronchodilators – anticholinergics, beta agonist
Inhaled corticosteroids- for patients with frequent exacerbations
Vaccination- influenza and pnuemococcal
Non pharmacotherapies- pulmonary rehabilitation, lung volume reduction surgery, lung transplantation
![Page 24: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/24.jpg)
Treatment of exacerbations Exacerbations are a prominent feature of
the natural history of COPD The frequency of exacerbations increases
as airflow obstruction increases Exacerbations are commonly considered to
be episodes of increased dyspnea and cough and change in the amount and character of sputum
Infections- bacteria most common cause of exacerbation
![Page 25: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/25.jpg)
Treatment includes-
Bronchodilators
Antibiotics
Glucocorticoids
Oxygen therapy
Mechanical ventilation
![Page 26: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/26.jpg)
Home O2 therapy for resting and nocturnal hypoxemia
Lung volume reduction surgery
![Page 27: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/27.jpg)
![Page 28: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/28.jpg)
Asthma
![Page 29: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/29.jpg)
Asthma
Asthma is a syndrome characterized by airflow obstruction that varies markedly, both spontaneously and with treatment
Narrowing of the airways is usually reversible, but in some patients with chronic asthma there may be an element of irreversible airflow obstruction
![Page 30: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/30.jpg)
Prevalence
~10–12% of adults and 15% of children affected by the disease
can present at any age
peak age is 3 years
![Page 31: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/31.jpg)
Children with asthma – the asthma can subside as they grow older.
Adults with asthma-rarely so
The severity of asthma does not vary significantly within a given patient
![Page 32: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/32.jpg)
Etiology
Asthma is a heterogeneous disease with interplay between genetic and environmental factors
![Page 33: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/33.jpg)
Genetic predisposition suggested by- familial association of asthma
high degree of concordance for asthma in identical twins
The severity of asthma is also genetically determined
Environmental factors-in early life determine which atopic individuals become asthmatic
![Page 34: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/34.jpg)
Atopy is the major risk factor for asthma Allergic rhinitis and atopic dermatitis
Allergens House dust mite
![Page 35: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/35.jpg)
Intrinsic Asthma or nonatopic asthma-~10% have negative skin test to common inhalant allergens and normal serum concentrations of IgE
Usual adult onset
![Page 36: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/36.jpg)
Pathogenesis Asthma is associated with a specific
chronic inflammation of the mucosa of the lower airways
The degree of inflammation is poorly related to disease severity and may be found in atopic patients without asthma symptoms
![Page 37: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/37.jpg)
Clinical features
Wheezing,
dyspnea, and
Cough
These are variable, both spontaneously and with therapy
Symptoms may be worse at night
Typical physical signs are inspiratory, and to a great extent expiratory, rhonchi throughout the chest
![Page 38: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/38.jpg)
Physical signs
wheezes
![Page 39: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/39.jpg)
Diagnosis
Simple spirometry confirms airflow limitation with a reduced FEV1,
FEV1/FVC ratio,
PEF
Reversibility is demonstrated by a >12% or 200 mL increase in FEV1 15 min after an inhaled short-acting beta 2-agonist or, in some patients, by a 2- to 4-week trial of oral glucocorticoids
methacholine or histamine challenge –rarely needed to confirm airway hyperresponsiveness
![Page 40: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/40.jpg)
Aims of treatment
For the patient to have
No or minimal symptoms esp. nocturnal
No emergency OPD visits
No frequent use of salbutamol
No limitation of activity
![Page 41: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/41.jpg)
Treatment
Two groups of drugs are used
Bronchodilators beta 2-adrenergic agonists,
anticholinergics, and
theophylline
Controllers Glucocorticoids
Antileukotriens
Cromones
antiIGE
Immunotherapy
![Page 42: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/42.jpg)
Management of chronic asthma
Avoid triggers
Pharmacotherapy –stepwise therapy
Patient education
Goals
Reduce impairment
Reduce risk
no cure but symptoms can be controlled
![Page 43: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/43.jpg)
Treatment of chronic asthma
First try to determine severity.
This can be done by looking at Reported symptoms over the previous two to four weeks
Night symptoms
Current level of lung function (FEV1 and FEV1/FVC values)
Number of exacerbations requiring oral glucocorticoids per year
Emergency visits
![Page 44: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/44.jpg)
Then stratify your patient by the severity to either
Intermittent
Mild persistent
Moderate persistent
Severe persistent
Then institute therapy by the level of severity
![Page 45: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/45.jpg)
![Page 46: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/46.jpg)
Adjusting therapy
Assess the status of the patient after 2-4 weeks of therapy.
If improving step down the treatment
If not step up the ladder.
![Page 47: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/47.jpg)
![Page 48: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/48.jpg)
Management of acute severe asthma
The best strategy for management of acute exacerbations of asthma is early recognition and intervention, before attacks become severe and potentially life threatening
Treatment starts with assessment of severity of attack
![Page 49: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/49.jpg)
Look for simple clinical severity indicators
Degree of dyspnea
Can the patient finish a sentence?
Degree of desaturation?
Paradoxic breathing, accessory muscles
Mental status
Silent chest
Level of V/S derangement
![Page 50: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/50.jpg)
Provide
High flow oxygen therapy to keep oxygen saturation >90%
High dose inhaled short acting beta agonists are the main stay of therapy (nebulized or via metered dose inhaler)
Add inhaled anticholinergics if no adequate response
![Page 51: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/51.jpg)
Start systemic glucocorticoids if there is not an immediate and marked response to the inhaled short-acting beta agonists
Slow infusion of aminophylline may be effective in patients not responding to high dose bronchodilators
Make frequent (every one to two hours) objective assessments of the response to therapy until definite, sustained improvement is documented
![Page 52: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/52.jpg)
For patients with respiratory failure, it is necessary to intubate and institute ventilation
Consider antibiotics if signs of pneumonia
![Page 53: Chronic obstructive pulmonary disease copy](https://reader036.vdocuments.net/reader036/viewer/2022062404/554b1e3eb4c90562098b52dd/html5/thumbnails/53.jpg)
Refractory asthma
A small proportion of patients (~5% of asthmatics) are difficult to control despite maximal inhaled therapy
Some of these patients will require maintenance treatment with oral corticosteroids
The most common reason for poor control of asthma is noncompliance with medication